Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration.

FTY720 Merkel Cell Polyomavirus NDRG1 PP2A SET

Journal

Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 13 02 2024
revised: 28 05 2024
accepted: 14 06 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 25 6 2024
Statut: aheadofprint

Résumé

Merkel Cell Carcinoma (MCC) is a rare neuroendocrine skin cancer. In our previous work, we decoded genes specifically deregulated by MCPyV early genes as opposed to other polyomaviruses and established functional importance of NDRG1 in inhibiting cellular proliferation and migration in MCC. In the present work, we found the SET protein, (I2PP2A, intrinsic inhibitor of PP2A) upstream of NDRG1 which was modulated by MCPyV early genes, both in hTERT-HK-MCPyV and MCPyV-positive (+) MCC cell lines. Additionally, MCC dermal tumour nodule tissues showed strong SET expression. Inhibition of the SET-PP2A interaction in hTERT-HK-MCPyV using the small molecule inhibitor, FTY720, increased NDRG1 expression and inhibited cell cycle regulators, cyclinD1 and CDK2. SET inhibition by shRNA and FTY720 also decreased cell proliferation and colony formation in MCPyV(+) MCC cells. Overall, these results pave a path for use of drugs targeting SET protein for the treatment of MCC.

Identifiants

pubmed: 38917692
pii: S0042-6822(24)00164-8
doi: 10.1016/j.virol.2024.110143
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110143

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Purnima Gupta (P)

International Agency for Research on Cancer, Lyon, France. Electronic address: purnimagupta1987@gmail.com.

Assunta Venuti (A)

International Agency for Research on Cancer, Lyon, France.

Michelle Savoldy (M)

Cancer Virology Program, University of Pittsburgh, Pittsburgh, PA, USA.

Alexis Harold (A)

Cancer Virology Program, University of Pittsburgh, Pittsburgh, PA, USA.

Francesco A Zito (FA)

Bari Dipartimento dei Servizi, U.O.C. di Anatomia Patologica, Istituto Tumori IRCCS "Giovanni Paolo II", Italy.

Valerio Taverniti (V)

International Agency for Research on Cancer, Lyon, France.

Maria Carmen Romero-Medina (MC)

International Agency for Research on Cancer, Lyon, France.

Luisa Galati (L)

International Agency for Research on Cancer, Lyon, France.

Cecilia Sirand (C)

International Agency for Research on Cancer, Lyon, France.

Naveed Shahzad (N)

School of Biological Sciences, University of the Punjab, Lahore, Pakistan.

Masahiro Shuda (M)

Cancer Virology Program, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: mas253@pitt.edu.

Tarik Gheit (T)

International Agency for Research on Cancer, Lyon, France. Electronic address: gheitt@iarc.who.in.

Rosita Accardi (R)

International Agency for Research on Cancer, Lyon, France.

Massimo Tommasino (M)

International Agency for Research on Cancer, Lyon, France.

Classifications MeSH